Millennium Management’s Dare Bioscience DARE Stock Holding History

Millennium Management’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,127	Closed	-$101K	–	6453
2022 Q4	$101K	Sell	10,127 -4,315	-30%	-$48.2K	﹤0.01%	5579
2022 Q3	$173K	Sell	14,442 -22,649	-61%	-$311K	﹤0.01%	5742
2022 Q2	$547K	Buy	37,091 +15,758	+74%	+$237K	﹤0.01%	4876
2022 Q1	$381K	Buy	+21,333	New	+$403K	﹤0.01%	5336
2021 Q4	–	Sell	-2,259	Closed	-$45K	–	6899
2021 Q3	$45K	Buy	+2,259	New	+$44.5K	﹤0.01%	6592
2017 Q4	–	Sell	-1,535	Closed	-$57K	–	3834
2017 Q3	$57K	Buy	+1,535	New	+$75.3K	﹤0.01%	3399
2016 Q3	–	Sell	-90	Closed	-$23K	–	3309
2016 Q2	$23K	Sell	90 -9	-9%	-$2.88K	﹤0.01%	3097
2016 Q1	$32K	Sell	99 -5	-5%	-$1.41K	﹤0.01%	3173
2015 Q4	$35K	Sell	104 -86	-45%	-$35.7K	﹤0.01%	3329
2015 Q3	$83K	Sell	190 -251	-57%	-$126K	﹤0.01%	3296
2015 Q2	$243K	Buy	+441	New	+$303K	﹤0.01%	2972
2014 Q3	–	Sell	-133	Closed	-$93K	–	3746
2014 Q2	$93K	Buy	+133	New	+$103K	﹤0.01%	3261

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

Millennium Management's DARE Position: Q1 2023 in Review

Millennium Management sold out of Dare Bioscience (DARE) in Q1 2023, closing a stake of 10,127 shares — an estimated $101K sold.

Millennium Management first reported a position in DARE in Q2 2014 and held it in 12 quarters. The position peaked at $547K in Q2 2022. 29 funds tracked by Wall St. Rank hold DARE as of Q1 2023.

Millennium Management reported no remaining Dare Bioscience position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 10,127 Dare Bioscience shares in Q1 2023, an estimated $101K.
Millennium Management first reported a position in Dare Bioscience in Q2 2014 and held it in 12 quarters.
Millennium Management's Dare Bioscience position peaked at $547K in Q2 2022.
29 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.